BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1933904)

  • 21. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
    Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
    J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors.
    Weiner TM; Liu ET; Craven RJ; Cance WG
    Ann Surg Oncol; 1994 Jan; 1(1):18-27. PubMed ID: 7834423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
    Lechner MS; Mack DH; Finicle AB; Crook T; Vousden KH; Laimins LA
    EMBO J; 1992 Aug; 11(8):3045-52. PubMed ID: 1379175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of the p53 gene in postradiation sarcoma.
    Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
    Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
    Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
    Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
    Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
    Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the retinoblastoma gene and their expression in somatic and tumor cells of patients with hereditary retinoblastoma.
    Kato MV; Ishizaki K; Toguchida J; Kaneko A; Takayama J; Tanooka H; Kato T; Shimizu T; Sasaki MS
    Hum Mutat; 1994; 3(1):44-51. PubMed ID: 8118465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
    Brachman DG; Hallahan DE; Beckett MA; Yandell DW; Weichselbaum RR
    Cancer Res; 1991 Dec; 51(23 Pt 1):6393-6. PubMed ID: 1933904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
    Wiman KG
    Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms for inactivation of tumor suppressor genes].
    Ishizaki K
    Nihon Rinsho; 1995 Nov; 53(11):2660-5. PubMed ID: 8538022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation-induced bone and soft tissue sarcomas: clinical aspects and molecular biology.
    Spiro IJ; Suit HD
    Cancer Treat Res; 1997; 91():143-55. PubMed ID: 9286494
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radiobiological considerations in radio-induced soft tissue sarcomas].
    Grigoriu M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):27-30. PubMed ID: 12089955
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.